Advanced search
Publication Cover
OncoImmunology Volume 10, 2021 - Issue 1
Submit an article Journal homepage
6,129
Views
14
CrossRef citations to date
0
Altmetric
Review

Advances in identification and selection of personalized neoantigen/T-cell pairs for autologous adoptive T cell therapies

Florian Kasta Roche Pharma Research & Early Development, Roche Innovation Center Zurich, Schlieren, SwitzerlandCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-5586-8382
ORCID Icon,
Christian Kleina Roche Pharma Research & Early Development, Roche Innovation Center Zurich, Schlieren, SwitzerlandORCID Iconhttps://orcid.org/0000-0001-7594-7280
ORCID Icon,
Pablo Umañaa Roche Pharma Research & Early Development, Roche Innovation Center Zurich, Schlieren, SwitzerlandORCID Iconhttps://orcid.org/0000-0001-8206-2771
ORCID Icon,
Alena Grosb Vall d’Hebron Institute of Oncology, Cellex Center, Barcelona, SpainORCID Iconhttps://orcid.org/0000-0002-1207-1880
ORCID Icon &
Stephan Gassera Roche Pharma Research & Early Development, Roche Innovation Center Zurich, Schlieren, SwitzerlandORCID Iconhttps://orcid.org/0000-0002-5616-0914
ORCID Icon
Article: 1869389 | Received 29 Oct 2020, Accepted 22 Dec 2020, Published online: 07 Jan 2021

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Xiang He, Shentao Zhang, Yuhang Tian, Wen Cheng & Hui Jing. (2023) Research Progress of Nanomedicine-Based Mild Photothermal Therapy in Tumor. International Journal of Nanomedicine 18, pages 1433-1468.
Read now

Articles from other publishers (13)

Meng-Yao Xu, Na Zeng, Chen-Qian Liu, Jian-Xuan Sun, Ye An, Si-Han Zhang, Jin-Zhou Xu, Xing-Yu Zhong, Si-Yang Ma, Hao-Dong He, Jia Hu, Qi-Dong Xia & Shao-Gang Wang. (2024) Enhanced cellular therapy: revolutionizing adoptive cellular therapy. Experimental Hematology & Oncology 13:1.
Crossref
Bouchra Derraz, Gabriele Breda, Christoph Kaempf, Franziska Baenke, Fabienne Cotte, Kristin Reiche, Ulrike Köhl, Jakob Nikolas Kather, Deborah Eskenazy & Stephen Gilbert. (2024) New regulatory thinking is needed for AI-based personalised drug and cell therapies in precision oncology. npj Precision Oncology 8:1.
Crossref
Marten Meyer, Christina Parpoulas, Titouan Barthélémy, Jonas P. Becker, Pornpimol Charoentong, Yanhong Lyu, Selina Börsig, Nadja Bulbuc, Claudia Tessmer, Lisa Weinacht, David Ibberson, Patrick Schmidt, Rüdiger Pipkorn, Stefan B. Eichmüller, Peter Steinberger, Katharina Lindner, Isabel Poschke, Michael Platten, Stefan Fröhling, Angelika B. Riemer, Jessica C. Hassel, Maria Paula Roberti, Dirk Jäger, Inka Zörnig & Frank Momburg. (2024) MediMer: a versatile do-it-yourself peptide-receptive MHC class I multimer platform for tumor neoantigen-specific T cell detection. Frontiers in Immunology 14.
Crossref
Renato Kaylan Alves França, Igor Cabral Studart, Marcus Rafael Lobo Bezerra, Larissa Queiroz Pontes, Antonio Marcos Aires Barbosa, Marcelo Macedo Brigido, Gilvan Pessoa Furtado & Andréa Queiroz Maranhão. (2023) Progress on Phage Display Technology: Tailoring Antibodies for Cancer Immunotherapy. Viruses 15:9, pages 1903.
Crossref
Alissa J. Cooper & Rebecca S. Heist. (2023) New Therapies on the Horizon. Hematology/Oncology Clinics of North America 37:3, pages 623-658.
Crossref
Ruichen Huang, Bi Zhao, Shi Hu, Qian Zhang, Xiaoping Su & Wei Zhang. (2023) Adoptive neoantigen-reactive T cell therapy: improvement strategies and current clinical researches. Biomarker Research 11:1.
Crossref
Rashmi Tippalagama, Leila Y. Chihab, Kendall Kearns, Sloan Lewis, Sudhasini Panda, Lisa Willemsen, Julie G. Burel & Cecilia S. Lindestam Arlehamn. (2023) Antigen-specificity measurements are the key to understanding T cell responses. Frontiers in Immunology 14.
Crossref
Rachel E. Sanborn, Famke L. Schneiders, Suresh Senan & Shirish M. Gadgeel. (2022) Beyond Checkpoint Inhibitors: Enhancing Antitumor Immune Response in Lung Cancer. American Society of Clinical Oncology Educational Book:42, pages 673-686.
Crossref
Meng Lv, Yan Liu, Wei Liu, Yabing Xing & Shengnan Zhang. (2022) Immunotherapy for Pediatric Acute Lymphoblastic Leukemia: Recent Advances and Future Perspectives. Frontiers in Immunology 13.
Crossref
Gianna T Flint, Patricia R Drake, Joel P Goetz, Marwah M Albaker & Julian N Rosenberg. (2021) Accelerating vein-to-vein cell therapy workflows with new bioanalytical strategies. Current Opinion in Biotechnology 71, pages 164-174.
Crossref
Estelle Baulu, Aurore Dougé, Nicolas Chuvin, Jacques-Olivier Bay & Stéphane Depil. (2021) Approches d’immunothérapie cellulaire T dans les tumeurs solides. Bulletin du Cancer 108:10, pages S96-S108.
Crossref
Benjamin C. Creelan, Chao Wang, Jamie K. Teer, Eric M. Toloza, Jiqiang Yao, Sungjune Kim, Ana M. Landin, John E. Mullinax, James J. Saller, Andreas N. Saltos, David R. Noyes, Leighann B. Montoya, Wesley Curry, Shari A. Pilon-Thomas, Alberto A. Chiappori, Tawee Tanvetyanon, Frederic J. Kaye, Zachary J. Thompson, Sean J. Yoder, Bin Fang, John M. Koomen, Amod A. Sarnaik, Dung-Tsa Chen, Jose R. Conejo-Garcia, Eric B. Haura & Scott J. Antonia. (2021) Tumor-infiltrating lymphocyte treatment for anti-PD-1-resistant metastatic lung cancer: a phase 1 trial. Nature Medicine 27:8, pages 1410-1418.
Crossref
Thomas Morgan Hulen, Christopher Aled Chamberlain, Inge Marie Svane & Özcan Met. (2021) ACT Up TIL Now: The Evolution of Tumor-Infiltrating Lymphocytes in Adoptive Cell Therapy for the Treatment of Solid Tumors. Immuno 1:3, pages 194-211.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.